Drug intelligence / Profile preview

5-aminolevulinic acid

Development stage
Approved
Lead developer
SBI Pharmaceuticals
Modality
Small Molecules
Administration
Oral, Topical, Intravenous
01

Overview

5-aminolevulinic acid is an endogenous, non-proteinogenic amino acid and heme-biosynthesis precursor used as a prodrug for photodynamic therapy and fluorescence-guided surgery. Following topical or systemic administration, cells metabolize it to **protoporphyrin IX**, which preferentially accumulates in many neoplastic or dysplastic tissues. Violet-blue light can be used to visualize red protoporphyrin IX fluorescence for surgical guidance, while illumination at an appropriate therapeutic wavelength generates reactive oxygen species and produces phototoxic tissue injury. Pharmaceutical products containing aminolevulinic acid or its hydrochloride salt are approved for actinic keratosis photodynamic therapy and for visualization of malignant tissue during glioma surgery; further clinical development includes fluorescence-guided breast-conserving surgery. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e45cc371-9ebc-4904-12bc-65cb4e2817ad))

Brand names
AmeluzGleolanGliolanLevulan Kerastick
Other names
aminolevulinic acid5-ALAdelta-aminolevulinic acidδ-aminolevulinic acid5-amino-4-oxopentanoic acid5-aminolevulinate
02

Targets

SLC15 (SLC15 family)

Beyond the preview

Go deeper on 5-aminolevulinic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-aminolevulinic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call